Articles > Popular publications > PR Newswire press releases > October-December 1995 > Thursday, October 26

Article: PIXYKINE PHASE III RESULTS IN TRANSPLANTATION SHOW BENEFIT SIMILAR TO CONTROL DRUG LEUKINE

Article from:
PR Newswire
Article date:
October 26, 1995
Copyright

SEATTLE, Oct. 26 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) today announced preliminary data analysis of a Phase III clinical study of the investigational new drug Pixykine(TM) (PIXY321) in the setting of bone marrow transplantation.

Results showed that Pixykine was safe and raised patients' platelets and neutrophils (white blood cells) as well as Leukine(R) (sargramostim), the control drug used in the study, but statistically significant improvement over those levels was not achieved in the trial. Leukine was approved in 1991 based on a Phase III study in transplant patients that showed a six-day improvement in white blood cell recovery, and a three-day ... 







Read all of this article with a FREE trial
















Related newspaper, magazine, and journal articles:









  




 

    

 
 
   
 


   
  
  Article: Neurocrine Biosciences Ramps Up Phase III Clinical ...

  
  PR Newswire; 
  March 19, 2002 ;  
  
  
 
  700+ words
... ... is initiating three additional pivotal Phase III clinical trials of NBI-34060 Immediate ... 1200 patients. The Company's first Phase III study with NBI-34060-IR was previously ... currently be conducting four of eight planned Phase III clinical trials with NBI-34060. According ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Phase III Medical Announces Appointment of ...

  
  Business Wire; 
  November 23, 2004 ;  
  
  
 
  700+ words
...MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM ... Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate ... biographical information on Dr. Marasco and Phase III Medical, please refer to the Company ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Santarus Announces Completion of Enrollment in European ...

  
  Business Wire; 
  December 3, 2009 ;  
  
  
 
  700+ words
... ... enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide ... conducted as part of the budesonide MMX Phase III clinical program. Santarus and Cosmo ... preliminary top line results from the European Phase III clinical trial in the first half of 2010 ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: CMS Releases Stark Phase III Regulations.(United ...

  
  Mondaq Business Briefing; 
  September 4, 2007 ;  
  
  
 
  700+ words
... ... copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that ... would be drastically altered, the Phase III revisions are for the most part ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Phase III Medical Completes Acquisition of NeoStem, ...

  
  Business Wire; 
  January 26, 2006 ;  
  
  
 
  700+ words
...MELVILLE, N.Y. -- Phase III Medical, Inc. (Phase III) (OTCBB:PHSM), has completed the acquisition of ... stem cells. Pursuant to the terms of the acquisition, Phase III, through its wholly owned subsidiary, has purchased ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Pain Therapeutics Announces Fourth Quarter and Year End 2004 ...

  
  PR Newswire; 
  January 26, 2005 ;  
  
  
 
  700+ words
... ... We ended the year with three drugs in Phase III clinical trials, nearly $100 million ... results now set the stage for a series of Phase III clinical announcements in 2005. After ... look forward to unblinding data from our Phase III trials and announcing clinical results ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Allergan Announces Positive Top-Line Results from Phase ...

  
  Business Wire; 
  September 11, 2008 ;  
  
  
 
  700+ words
...-- Phase III Studies Show Statistically Significant ... completed a top-line analysis of its two Phase III clinical trials exploring the use of ... pleased with the top-line results of our Phase III clinical trials which show that BOTOX ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: InterMune Provides Update on Its Two Phase III ...

  
  PR Newswire; 
  October 17, 2005 ;  
  
  
 
  700+ words
...- Phase III INSPIRE Trial on Track to Conclude Around the End of 2007 - - Design of Phase III Pirfenidone Program Finalized - - Company ... Inc. today provided an update on its two Phase III programs evaluating two separate compounds ... 







   
 

























 



 





 






Newsweek
Harper's Magazine
The Washington Post
Chicago Tribune
Crain's Chicago Business
PRNewswire
Pediatric News
The Nation
Advertising Age
The Economist (US)
A FREE trial gives you access to over 80 million articles!
Access over 6,500 publications with a FREE trial!


  



Find articles, research, and archives